On February 27, 2026, the Company’s Board of Directors approved the transfer of 100% equity interests in Visionary Education Services & Management Inc., completing the planned exit from non-core legacy operations. With this divestiture, Visionary Holdings (GV) will operate as a streamlined biotechnology and healthcare-focused enterprise, allocating capital, technology and management resources exclusively toward: Anti-aging injectable products; Regenerative medical aesthetics; Biotechnology-driven healthcare innovation. The product is intended for aesthetic and wellness applications and is not intended to diagnose, treat, cure, or prevent any disease.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GV:
- Visionary Holdings provides execution update on $9M sales contract
- Visionary Holdings establishes three subsidiaries in Qingdao, Wuxi, Wuhu
- Visionary Holdings regains compliance with Nasdaq periodic filing rule
- Visionary Holdings Overhauls Governance and Seals Key Deals in Pivot to High-End Anti-Aging Aesthetics